Latest Merck & Co Inc News

Drugmaker Merck tops 3Q forecasts as Keytruda sales jump 20%

Oct. 27, 2022 08:23 AM EDT

Merck turned in a better-than-expected third quarter and raised its 2022 forecast as the drugmaker’s top seller brought in over a third of its revenue. Sales of the cancer fighter Keytruda grew 20% to more than $5.4 billion in the quarter and would have jumped 26% without the...